Cargando…
Monoamine oxidase A (MAO A) inhibitors decrease glioma progression
Glioblastoma (GBM) is an aggressive brain tumor which is currently treated with temozolomide (TMZ). Tumors usually become resistant to TMZ and recur; no effective therapy is then available. Monoamine Oxidase A (MAO A) oxidizes monoamine neurotransmitters resulting in reactive oxygen species which ca...
Autores principales: | Kushal, Swati, Wang, Weijun, Vaikari, Vijaya Pooja, Kota, Rajesh, Chen, Kevin, Yeh, Tzu-Shao, Jhaveri, Niyati, Groshen, Susan L., Olenyuk, Bogdan Z., Chen, Thomas C., Hofman, Florence M., Shih, Jean C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924682/ https://www.ncbi.nlm.nih.gov/pubmed/26871599 http://dx.doi.org/10.18632/oncotarget.7283 |
Ejemplares similares
-
Marine natural products with monoamine oxidase (MAO) inhibitory activity
por: Hong, Ahreum, et al.
Publicado: (2020) -
β-Carboline Alkaloids in Soy Sauce and Inhibition of Monoamine Oxidase (MAO)
por: Herraiz, Tomás
Publicado: (2023) -
Monoamine Oxidase Inhibitory Constituents of Propolis: Kinetics and Mechanism of Inhibition of Recombinant Human MAO-A and MAO-B
por: Chaurasiya, Narayan D., et al.
Publicado: (2014) -
Three Dimensional Pharmacophore Modelling of Monoamine oxidase-A (MAO-A) inhibitors
por: Sairam, Kalapatapu V.V.M., et al.
Publicado: (2007) -
Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis
por: Yeung, Andy Wai Kan, et al.
Publicado: (2019)